Radical cystectomy remains a major operation even at experienced centers and with robotic surgical techniques. Data from the ...

The 2026 ESMO annual meeting featured a prostate cancer session and a presentation by Dr. Mehdi Bsilat discussing the impact ...

Most CTC-evaluable patients in TALAPRO-2 had relatively low CTC burden at baseline, with 81.5% having <5 CTCs/7.5 mL and 65.3 ...

(UroToday.com) The 2026 European Society of Medical Oncology (ESMO) Annual Congress held the session: Genitourinary tumour, ...

The 2026 ESMO annual meeting featured a rapid oral session and a discussant presentation by Dr. Alison Reid discussing three ...

(UroToday.com) The 2026 North Central Section of the AUA annual meeting featured a prostate cancer session and a presentation ...

This analysis included 58 patients treated with gemcitabine intravesical system monotherapy in the SunRISe-1 cohort who had available utDNA molecular residual disease results at baseline or week 12.

The 2026 North Central Section of the AUA annual meeting featured a urothelial carcinoma session and a presentation by Dr. Akshay Sood discussing the germline mutational landscape and survival ...

The 2026 North Central Section of the AUA annual meeting featured a bladder cancer session and a presentation by Dr. Kaitlin Davis discussing regional disparities in bladder cancer mortality rates.

(UroToday.com) The 2026 ProsTIC annual meeting featured a best-selected posters session and a presentation by Dr. Mevan Ekanayake discussing PETomics, integration of PET imaging and ctDNA genomics via ...

San Francisco, California (UroToday.com) Based on preclinical data from mouse models looking at radiation therapy combined with dual anti-PDL1 and anti-CTLA4 immune checkpoint blockade in cancer that ...

Spatial Architecture Contributes to Failure of Bulk Biomarker-Guided Neoadjuvant Immunotherapy Selection in Bladder Cancer: The DUTRENEO Study - Beyond the Abstract ...